Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.11 HKD
1.94 B HKD
31.30 B HKD
9.46 B
About SINO BIOPHARMACEUTICAL
Sector
Industry
CEO
S Y Tse
Website
Headquarters
Hong Kong
Founded
2000
FIGI
BBG000C6XDL4
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.
#1177 Good Support at $6.18 LevelHi Everybody
#1177 shows good support at $6.18 Level since July, it aims for the BLUE LINES, and stop if close below the RED Line.
LONG 1177Expecting bounce from extremely oversold weekly and daily levels. If stop breached, be prepared to catch new daily reversal on lower levels with a tight stop.
Double three of lesser degree formation possibleThe wave theory suggests HKEX:1177 that the prolong flat correction will be prolonged at least for the midterm period
Sino Biopharma- Double three in action. HKEX:1177
Current wave analysis suggests that the stock has already completed a regular flat and zig-zag action.
Price action suggest that the stock is heading for further downside correction as rising wedge formation gave some hint that the stock is losing its steam on bullish momentum.
Thursda
1177, Sino Biopharm - Trailing Stop and Ascending TriangleHKEX:1177
After our long entry on the head and shoulders of reversing, we are managing the position by gradually moving the stop profits below the last lows.
Currently an upward triangle is forming within our trailing stop, which if it broke the resistance level would probably further give a bullis
1177, Sino Biopharm - Trailing Stop after Breakingout on H&SHKEX:1177
Here too we continue to move the stop loss in trailing stop mode, until we reach our primary objective, that is Break Even Point, equal to the entry point plus commissions.
Remember that Risk Management and Position Sizing are the fundamental points to have a positive trading operation.
S
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of 1177 is 3.95 HKD — it has increased by 1.54% in the past 24 hours. Watch SINO BIOPHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SINO BIOPHARMACEUTICAL stocks are traded under the ticker 1177.
1177 stock has risen by 9.42% compared to the previous week, the month change is a 10.64% rise, over the last year SINO BIOPHARMACEUTICAL has showed a 47.94% increase.
We've gathered analysts' opinions on SINO BIOPHARMACEUTICAL future price: according to them, 1177 price has a max estimate of 6.16 HKD and a min estimate of 3.77 HKD. Watch 1177 chart and read a more detailed SINO BIOPHARMACEUTICAL stock forecast: see what analysts think of SINO BIOPHARMACEUTICAL and suggest that you do with its stocks.
1177 reached its all-time high on Jul 22, 2020 with the price of 11.24 HKD, and its all-time low was 0.07 HKD and was reached on Jan 14, 2004. View more price dynamics on 1177 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1177 stock is 5.12% volatile and has beta coefficient of 1.02. Track SINO BIOPHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is SINO BIOPHARMACEUTICAL there?
Today SINO BIOPHARMACEUTICAL has the market capitalization of 72.35 B, it has increased by 2.51% over the last week.
Yes, you can track SINO BIOPHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
SINO BIOPHARMACEUTICAL is going to release the next earnings report on Aug 28, 2025. Keep track of upcoming events with our Earnings Calendar.
1177 earnings for the last half-year are 0.032 HKD per share, whereas the estimation was 0.085 HKD, resulting in a −62.50% surprise. The estimated earnings for the next half-year are 0.085 HKD per share. See more details about SINO BIOPHARMACEUTICAL earnings.
SINO BIOPHARMACEUTICAL revenue for the last half-year amounts to 13.83 B HKD, despite the estimated figure of 15.07 B HKD. In the next half-year revenue is expected to reach 19.10 B HKD.
1177 net income for the last half-year is 376.73 M HKD, while the previous report showed 1.56 B HKD of net income which accounts for −75.91% change. Track more SINO BIOPHARMACEUTICAL financial stats to get the full picture.
SINO BIOPHARMACEUTICAL dividend yield was 2.19% in 2024, and payout ratio reached 65.98%. The year before the numbers were 1.44% and 35.95% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 27, 2025, the company has 24.38 K employees. See our rating of the largest employees — is SINO BIOPHARMACEUTICAL on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SINO BIOPHARMACEUTICAL EBITDA is 8.17 B HKD, and current EBITDA margin is 26.04%. See more stats in SINO BIOPHARMACEUTICAL financial statements.
Like other stocks, 1177 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINO BIOPHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SINO BIOPHARMACEUTICAL technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SINO BIOPHARMACEUTICAL stock shows the buy signal. See more of SINO BIOPHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.